Cumberland Pharmaceuticals (CPIX) Return on Capital Employed Growth (3y) (2014 - 2026)
Cumberland Pharmaceuticals (CPIX) Return on Capital Employed Growth (3y) (2014 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.07 Bn | 43.10 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.41 Bn | 39.75 Bn | 2.15 Bn | 1,036.00 |
| 3 | Zoetis | 31.83 Bn | 30.15 Bn | 1.05 Bn | 175.00 |
| 4 | Takeda Pharmaceutical | 28.77 Bn | 22.97 Bn | 5.10 Bn | 120.00 |
| 5 | United Therapeutics | 22.27 Bn | 19.61 Bn | 683.80 Mn | 434.00 |
| 6 | Viatris | 18.76 Bn | 17.87 Bn | 1.46 Bn | -295.00 |
| 7 | Neurocrine Biosciences | 15.65 Bn | 15.26 Bn | 935.80 Mn | 1,076.00 |
| 8 | Elanco Animal Health | 11.93 Bn | 11.40 Bn | 798.00 Mn | 1,898.00 |
| 9 | Dr Reddys Laboratories | 10.16 Bn | 10.00 Bn | - | - |
| 10 | Cumberland Pharmaceuticals | 116.48 Mn | 112.62 Mn | - | -2,380.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -2,380.00 |
| Mar 31, 2026 | -922.00 |
| Dec 31, 2025 | 95.00 |
| Sep 30, 2025 | 407.00 |
| Jun 30, 2025 | 622.00 |
| Mar 31, 2025 | 617.00 |
| Dec 31, 2024 | -294.00 |
| Sep 30, 2024 | -1,592.00 |
| Jun 30, 2024 | -1,329.00 |
| Mar 31, 2024 | -1,117.00 |
| Dec 31, 2023 | -778.00 |
| Sep 30, 2023 | 179.00 |
| Jun 30, 2023 | 687.00 |
| Mar 31, 2023 | 294.00 |
| Dec 31, 2022 | 259.00 |
| Sep 30, 2022 | -209.00 |
| Jun 30, 2022 | -525.00 |
| Mar 31, 2022 | -578.00 |
| Dec 31, 2021 | -128.00 |
| Sep 30, 2021 | 100.00 |